Katherine Therese Ward, MD
Geriatric Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: 059765 · Stanford Health Care · 055466. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ward’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A75695 · Current
Licensed to practise in California · since 2001 · expires 2027-02-28 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$48,542
Medicare paid this office $48,542 for 191 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 52 | $10,961 | $120 |
| New patient visit (60+ min) | 68 | $10,853 | $160 |
| Telephone medical discussion with physician, 21-30 minutes | 24 | $4,700 | $124 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $2,949 | $140 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 16 | $2,804 | $165 |
See all 10 services
| Long return visit (40+ min) | 52 | $10,961 | $120 |
| New patient visit (60+ min) | 68 | $10,853 | $160 |
| Telephone medical discussion with physician, 21-30 minutes | 24 | $4,700 | $124 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $2,949 | $140 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 16 | $2,804 | $165 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 22 | $2,581 | $99 |
| Nursing facility discharge management, more than 30 minutes | 15 | $1,897 | $119 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,724 | $133 |
| Return visit (30+ min) | 18 | $1,394 | $73 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 57 | $1,165 | $15 |
Who their Medicare patients are
191 Original Medicare patients in 2024. Average age 86 · Under 65 0% · 85 and older 59% · Women 63% · Also on Medicaid 14% · Health risk score 1.94. Above the middle of the specialty; the typical geriatric medicine clinician is at 1.84.
Conditions among them: High blood pressure 75% · Dementia 45% · Atrial fibrillation 38% · Depression 38% · Coronary heart disease 32% · Chronic kidney disease 31% · Diabetes 30% · Heart failure 27% · Stroke 24% · Cancer 23% · COPD 18%.
The office billed $141,509, Medicare allowed $61,447 and paid $48,542; for 468 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 191 | 468 | 86 | 1.94 | $141,509 | $48,542 |
| 2015 | 109 | 286 | 76 | 1.69 | $102,264 | $25,527 |
| 2014 | 140 | 433 | 74 | 1.86 | $131,048 | $33,985 |
| 2013 | 140 | 258 | 70 | 1.76 | $55,558 | $14,049 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2015: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $14,091 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,654 | $166 |
| Return visit (30+ min) | 22 | $1,788 | $62 |
| Short return visit (20+ min) | 19 | $632 | $32 |
2014: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $22,170 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $5,247 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,886 | $170 |
| Return visit (30+ min) | 26 | $1,769 | $63 |
| Short return visit (20+ min) | 27 | $1,287 | $40 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $4,097 | $84 |
| Short return visit (20+ min) | 71 | $3,188 | $38 |
| Return visit (30+ min) | 40 | $2,589 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,637 | $58 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $117 | $6 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 362 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Discharge medications reconciled with the current medication list in outpatient medical record (COA) (GER) | 37 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 52 | $0 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 153 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 70 | $0 |
| Hemoglobin A1C level | 13 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 37 | $0 |
| 2024 | 362 | 6 | 23 | $0 |
| 2023 | 972 | 8 | 31 | $0 |
| 2022 | 635 | 5 | 23 | $0 |
| 2021 | 290 | 5 | 36 | $0 |
| 2020 | 59 | 1 | 15 | $0 |
See the largest Medicaid services in earlier years
2023
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 381 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 232 | $0 |
| Hemoglobin A1C level | 28 | $0 |
| Thyroid stimulating hormone (TSH) | 13 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 173 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 17 | $0 |
| OFF/OP EST MAY X REQ PHY/QHP | 47 | $0 |
| Return visit (30+ min) | 81 | $0 |
2022
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 276 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 160 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 145 | $0 |
| OFF/OP EST MAY X REQ PHY/QHP | 39 | $0 |
| Return visit (30+ min) | 15 | $0 |
2021
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 117 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 16 | $0 |
| Hemoglobin A1C level | 13 | $0 |
| OFF/OP EST MAY X REQ PHY/QHP | 128 | $0 |
| Return visit (30+ min) | 16 | $0 |
2020
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 59 | $0 |
Drugs they prescribed that Part D paid
$46,794
Pharmacies billed $46,794 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (18 of 684) in 2024. Above the middle of the specialty; the typical geriatric medicine clinician is at 2%.
610 generic and 74 brand-name prescriptions · $46,794 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $9,781 | $889 |
| Mirtazapine | 14 | $888 | $63 |
| Levothyroxine | 41 | $633 | $15 |
| Sertraline | 26 | $483 | $19 |
| Atorvastatin | 37 | $419 | $11 |
See all 18 drugs
| Eliquis | 11 | $9,781 | $889 |
| Mirtazapine | 14 | $888 | $63 |
| Levothyroxine | 41 | $633 | $15 |
| Sertraline | 26 | $483 | $19 |
| Atorvastatin | 37 | $419 | $11 |
| Pantoprazole | 16 | $316 | $20 |
| Losartan | 36 | $296 | $8 |
| Diclofenac | 11 | $250 | $23 |
| Escitalopram | 20 | $247 | $12 |
| Metoprolol | 18 | $184 | $10 |
| Oxycodone | 15 | $183 | $12 |
| Alendronate | 16 | $181 | $11 |
| Omeprazole | 20 | $152 | $8 |
| Amlodipine Besylate | 25 | $112 | $4 |
| Metformin | 16 | $83 | $5 |
| Furosemide | 20 | $57 | $3 |
| Trazodone | 12 | $54 | $4 |
| Lisinopril | 14 | $50 | $4 |
Year by year
| 2024 | 684 | 154 | 3% (18) | 11% | $46,794 |
| 2023 | 581 | 61 | None | 13% | $41,185 |
| 2022 | 530 | 58 | None | None | $30,716 |
| 2021 | 343 | 40 | None | None | $34,112 |
| 2020 | 360 | 44 | None | None | $53,703 |
| 2019 | 472 | 49 | None | None | $32,284 |
| 2018 | 466 | 47 | 3% (14) | None | $25,113 |
| 2017 | 388 | 50 | 3% (13) | 16% | $25,456 |
| 2016 | 339 | 44 | 6% (21) | None | $13,787 |
| 2015 | 572 | 67 | 2% (14) | None | $22,049 |
| 2014 | 645 | 88 | 3% (20) | 22% | $34,850 |
| 2013 | 784 | 76 | None | None | $49,631 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Xarelto | 11 | $9,957 | $905 |
| Atorvastatin | 58 | $1,605 | $28 |
| Losartan | 26 | $744 | $29 |
| Amlodipine Besylate | 38 | $693 | $18 |
| Omeprazole | 19 | $568 | $30 |
| Metformin | 27 | $555 | $21 |
| Diclofenac | 19 | $382 | $20 |
| Lisinopril | 17 | $333 | $20 |
| Albuterol Sulfate Hfa | 11 | $318 | $29 |
| Hydrochlorothiazide | 23 | $288 | $13 |
| Fluticasone Propionate | 12 | $279 | $23 |
| Metoprolol | 11 | $189 | $17 |
| Furosemide | 17 | $133 | $8 |
2022: 10 drugs
| Atorvastatin | 59 | $869 | $15 |
| Diclofenac | 19 | $614 | $32 |
| Metformin | 37 | $403 | $11 |
| Amlodipine Besylate | 32 | $282 | $9 |
| Omeprazole | 19 | $210 | $11 |
| Losartan | 20 | $153 | $8 |
| Metoprolol | 18 | $133 | $7 |
| Spironolactone | 13 | $107 | $8 |
| Hydrochlorothiazide | 17 | $101 | $6 |
| Furosemide | 14 | $74 | $5 |
2021: 5 drugs
| Diclofenac | 13 | $962 | $74 |
| Atorvastatin | 24 | $340 | $14 |
| Metformin | 20 | $206 | $10 |
| Losartan | 14 | $180 | $13 |
| Amlodipine Besylate | 19 | $162 | $9 |
2020: 9 drugs
| Anoro Ellipta | 12 | $5,322 | $443 |
| Atorvastatin | 31 | $370 | $12 |
| Metoprolol | 11 | $329 | $30 |
| Diclofenac | 12 | $260 | $22 |
| Losartan | 14 | $178 | $13 |
| Amlodipine Besylate | 22 | $134 | $6 |
| Metformin | 14 | $122 | $9 |
| Lisinopril | 11 | $72 | $7 |
| Furosemide | 11 | $63 | $6 |
2019: 13 drugs
| Atorvastatin | 38 | $710 | $19 |
| Gabapentin | 12 | $465 | $39 |
| Lidocaine-Prilocaine | 14 | $295 | $21 |
| Metformin | 25 | $288 | $12 |
| Omeprazole | 22 | $270 | $12 |
| Amlodipine Besylate | 24 | $197 | $8 |
| Tamsulosin | 13 | $195 | $15 |
| Carvedilol | 21 | $173 | $8 |
| Lisinopril | 16 | $168 | $10 |
| Losartan | 18 | $135 | $8 |
| Hydrochlorothiazide | 14 | $115 | $8 |
| Citalopram Hbr | 14 | $103 | $7 |
| Furosemide | 11 | $72 | $7 |
2018: 17 drugs
| Voltaren | 13 | $771 | $59 |
| Ventolin Hfa | 13 | $728 | $56 |
| Atorvastatin | 29 | $619 | $21 |
| Metformin | 17 | $347 | $20 |
| Latanoprost | 13 | $255 | $20 |
| Lidocaine-Prilocaine | 11 | $243 | $22 |
| Gabapentin | 18 | $236 | $13 |
| Lisinopril | 14 | $234 | $17 |
| Potassium Chloride | 13 | $214 | $16 |
| Levothyroxine | 12 | $212 | $18 |
| Metoprolol | 21 | $168 | $8 |
| Carvedilol | 13 | $161 | $12 |
| Omeprazole | 16 | $152 | $10 |
| Amlodipine Besylate | 19 | $115 | $6 |
| Furosemide | 14 | $87 | $6 |
| Citalopram Hbr | 12 | $79 | $7 |
| Tramadol | 13 | $23 | $2 |
2017: 11 drugs
| Atorvastatin | 24 | $671 | $28 |
| Gabapentin | 17 | $273 | $16 |
| Omeprazole | 14 | $231 | $17 |
| Metformin | 11 | $199 | $18 |
| Lisinopril | 14 | $198 | $14 |
| Amlodipine Besylate | 32 | $179 | $6 |
| Tamsulosin | 15 | $155 | $10 |
| Potassium Chloride | 13 | $149 | $11 |
| Furosemide | 15 | $77 | $5 |
| Hydrochlorothiazide | 13 | $54 | $4 |
| Tramadol | 12 | $22 | $2 |
2016: 10 drugs
| Atorvastatin | 27 | $517 | $19 |
| Gabapentin | 29 | $476 | $16 |
| Hydralazine | 11 | $227 | $21 |
| Lisinopril | 16 | $142 | $9 |
| Omeprazole | 15 | $137 | $9 |
| Losartan | 13 | $135 | $10 |
| Amlodipine Besylate | 16 | $108 | $7 |
| Metoprolol | 15 | $101 | $7 |
| Metformin | 13 | $96 | $7 |
| Tramadol | 17 | $88 | $5 |
2015: 14 drugs
| Atorvastatin | 53 | $987 | $19 |
| Pravastatin | 14 | $622 | $44 |
| Omeprazole | 42 | $556 | $13 |
| Metoprolol | 20 | $379 | $19 |
| Gabapentin | 18 | $248 | $14 |
| Metformin | 25 | $223 | $9 |
| Amlodipine Besylate | 30 | $196 | $7 |
| Metoprolol | 28 | $180 | $6 |
| Hydrochlorothiazide | 29 | $148 | $5 |
| Benazepril | 15 | $144 | $10 |
| Lisinopril | 27 | $139 | $5 |
| Alendronate | 22 | $118 | $5 |
| Furosemide | 15 | $65 | $4 |
| Simvastatin | 12 | $36 | $3 |
2014: 16 drugs
| Premarin | 13 | $2,091 | $161 |
| Oxybutynin Chloride Er | 15 | $703 | $47 |
| Furosemide | 33 | $672 | $20 |
| Atorvastatin | 25 | $661 | $26 |
| Metoprolol | 15 | $488 | $33 |
| Pravastatin | 14 | $419 | $30 |
| Lisinopril | 40 | $363 | $9 |
| Omeprazole | 26 | $254 | $10 |
| Tamsulosin | 15 | $250 | $17 |
| Amlodipine Besylate | 19 | $167 | $9 |
| Metoprolol | 19 | $159 | $8 |
| Metformin | 18 | $155 | $9 |
| Hydrochlorothiazide | 23 | $119 | $5 |
| Simvastatin | 18 | $97 | $5 |
| Warfarin | 15 | $86 | $6 |
| Alendronate | 11 | $65 | $6 |
2013: 20 drugs
| Nexium | 18 | $2,112 | $117 |
| Mirtazapine | 23 | $1,195 | $52 |
| Atorvastatin | 22 | $721 | $33 |
| Pravastatin | 20 | $645 | $32 |
| Carbidopa-Levodopa | 11 | $605 | $55 |
| Tamsulosin | 18 | $546 | $30 |
| Pyridostigmine | 11 | $522 | $47 |
| Metoprolol | 11 | $399 | $36 |
| Famotidine | 16 | $381 | $24 |
| Olanzapine | 12 | $373 | $31 |
| Simvastatin | 35 | $368 | $11 |
| Lisinopril | 35 | $353 | $10 |
| Alendronate | 13 | $321 | $25 |
| Levothyroxine | 21 | $316 | $15 |
| Amlodipine Besylate | 28 | $279 | $10 |
| Metoprolol | 26 | $250 | $10 |
| Donepezil | 11 | $195 | $18 |
| Metformin | 19 | $179 | $9 |
| Furosemide | 33 | $167 | $5 |
| Hydrochlorothiazide | 17 | $141 | $8 |
Money from drug and device companies
$177 in 2025
A payment is not proof that care is biased.
| Kerecis | Kerecis Surgiclose | $177 | 1 payment
|
See the published payment
| Kerecis | Meals · 2025-07-24 | Kerecis Surgiclose | $177 |
Professional record
- NPI
- 1184644262
- Licence
- CA A75695California A75695: Current · expires 2027-02-28
- Trained
- St. Louis College of Physicians and Surgeons, 1998
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A756950
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RG0300X (207RG0300X); Federal specialty code 207RH0002X (207RH0002X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-20
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.